title: Once daily risperidone in treatment of schizophrenia.
abstract: Forty four schizophrenic patients were randomly assigned to receive risperidone in 4-8 mg doses either once daily or twice daily for 8 weeks. An open trial was conducted to determine the efficacy of once daily administration of risperidone as compared to twice daily administration. Assessment were done on Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression (CGI) scale Eighty two percent of the once daily patients and 79% of the twice daily patients showed a significant treatment response. No significant differences were observed between the two groups in response pattern and adverse effects at the end point. Risperidone given once daily was as effective as twice daily administration.
authors.affiliation: VIVEK AGARWAL, MD., Senior Resident, Department of Psychiatry, Institute of Human Behaviour & Allied Sciences, P.O. Box 9520, Dilshad Garden, Delhi - 110 095.
authors.forename: V
authors.initials: V
authors.lastname: Agarwal
authors.forename: R K
authors.initials: RK
authors.lastname: Chadda